Prosecution Insights
Last updated: April 19, 2026

The Johns Hopkins University

15 pending office actions • 6 clients

Portfolio Summary

15
Total Pending OAs
4
Final Rejections
11
Non-Final OAs

Client Portfolio (6 clients)

Client (Assignee)Pending OAs
The Johns Hopkins University 10
Kennedy Krieger Institute, Inc. 1
Memorial Sloan Kettering Cancer Center 1
Capricor, Inc. 1
The Johns Hopkins University 1
UNIVERSITY OF MARYLAND, BALTIMORE 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18774198 DENDRIMER COMPOSITIONS AND USE IN TREATMENT OF NEUROLOGICAL AND CNS DISORDERS Kennedy Krieger Institute, Inc. DICKINSON, PAUL W 1618 Non-Final OA Jul 16, 2024
18521505 TISSUE ABLATION AND ASSESSMENT SYSTEM AND METHOD OF USE THEREOF The Johns Hopkins University PEFFLEY, MICHAEL F 3794 Non-Final OA Nov 28, 2023
18275586 BINDING PEPTIDES AND USES THEREOF The Johns Hopkins University MARTINEZ, TARA L 1654 Non-Final OA Aug 02, 2023
18039660 USE OF ACTIVATED T-CELLS TO ENHANCE ANTI-TUMOR ACTIVITY OF BISPECIFIC ANTIBODIES OR BITES Memorial Sloan Kettering Cancer Center DONOGHUE, BRITTNEY ERIN 1675 Non-Final OA May 31, 2023
18033925 METHOD FOR DETECTION OF ANTIGEN-SPECIFIC ANTIBODY The Johns Hopkins University LI, BAO Q 1671 Non-Final OA Apr 26, 2023
18306872 NON-LINEAR MULTIBLOCK COPOLYMER-DRUG CONJUGATES FOR THE DELIVERY OF ACTIVE AGENTS The Johns Hopkins University PIPIC, ALMA 1617 Non-Final OA Apr 25, 2023
18044405 GALACTOSYLATED DENDRIMERS FOR TARGETED INTRACELLULAR DELIVERY TO HEPATOCYTES The Johns Hopkins University VAN DRUFF, SYDNEY 1643 Non-Final OA Mar 08, 2023
17997006 COMPOSITIONS AND METHODS COMPRISING DENDRIMERS AND THERAPEUTIC AGENTS The Johns Hopkins University BELL, SARA ELIZABETH 1625 Final Rejection Oct 24, 2022
17909971 SELECTABLE MARKER PROTEINS, EXPRESSION VECTORS, ENGINEERED CELLS AND EXTRACELLULAR VESICLES FOR THE PRODUCTION OF VIRUS-LIKE PARTICLES FOR THERAPEUTIC AND PROPHYLACTIC APPLICATIONS Capricor, Inc. NOAKES, SUZANNE MARIE 1656 Non-Final OA Sep 07, 2022
17800838 SUPRACHOROIDAL DELIVERY OF DRUG PARTICLES TO REDUCE TOXICITY The Johns Hopkins University FAY, ZOHREH ALEMZADEH 1617 Final Rejection Aug 18, 2022
17797676 CANCER IMMUNOTHERAPY USING TRANSFUSIONS OF ALLOGENEIC, TUMOR-SPECIFIC CD4+ T CELLS The Johns Hopkins University DENT, ALANA HARRIS 1643 Non-Final OA Aug 04, 2022
17633917 BIOMARKERS FOR NEURODEGENERATIVE DISORDERS The Johns Hopkins University FRITCHMAN, REBECCA M 1758 Final Rejection Feb 08, 2022
17312916 HIV SEROSIGNATURES FOR CROSS-SECTIONAL INCIDENCE ESTIMATION The Johns Hopkins University STUART, CAREY ALEXANDER MC 1671 Final Rejection Jun 10, 2021
16990572 DNA METHYLATION BIOMARKERS OF POST-PARTUM DEPRESSION RISK UNIVERSITY OF MARYLAND, BALTIMORE SITTON, JEHANNE SOUAYA 1682 Non-Final OA Aug 11, 2020
16809496 METHOD OF IDENTIFYING RISK FOR AUTISM The Johns Hopkins University HANEY, AMANDA MARIE 1682 Non-Final OA Mar 04, 2020

Managing The Johns Hopkins University's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month